D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
2626
CALL
DELISTED
Radius Health, Inc.
RDUS
| $881K | ﹤0.01% |
44,200
| – | – |
|
|
CCRN
2627
DELISTED
Cross Country Healthcare
CCRN
| $880K | ﹤0.01% |
125,165
+11,046
| +10% | +$94.7K |
|
2628
PUT
HF Sinclair
DINO
$16.4B
| $877K | ﹤0.01% |
17,800
-60,700
| -77% | -$3.23M |
|
2629
CALL
Rockwell Automation
ROK
$51.9B
| $877K | ﹤0.01% |
5,000
-45,000
| -90% | -$7.65M |
|
2630
Acushnet Holdings
GOLF
$6.08B
| $876K | ﹤0.01% |
37,829
-34,078
| -47% | -$797K |
|
2631
Dime Commercial Bancshares
DCOM
$1.77B
| $875K | ﹤0.01% |
29,842
+5,484
| +23% | +$166K |
|
|
UMH
2632
UMH Properties
UMH
$1.32B
| $875K | ﹤0.01% |
62,138
-19,277
| -24% | -$259K |
|
|
MANT
2633
DELISTED
Mantech International Corp
MANT
| $874K | ﹤0.01% |
+16,188
| New | +$887K |
|
2634
Plug Power
PLUG
$2.87B
| $873K | ﹤0.01% |
363,572
-1,419,572
| -80% | -$2.48M |
|
2635
PUT
Carvana
CVNA
$45.9B
| $871K | ﹤0.01% |
75,000
-39,500
| -34% | -$332K |
|
2636
CALL
C.H. Robinson
CHRW
$20.6B
| $870K | ﹤0.01% |
10,000
-5,000
| -33% | -$439K |
|
2637
Core Laboratories
CLB
$518M
| $870K | ﹤0.01% |
12,624
-39,465
| -76% | -$2.65M |
|
|
MNK
2638
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $870K | ﹤0.01% |
40,000
-3,500
| -8% | -$74.6K |
|
2639
PUT
Incyte
INCY
$23.7B
| $869K | ﹤0.01% |
10,100
-118,000
| -92% | -$9.6M |
|
2640
Invitation Homes
INVH
$17.6B
| $868K | ﹤0.01% |
+35,691
| New | +$803K |
|
2641
Ball Corp
BALL
$17.2B
| $867K | ﹤0.01% |
+14,992
| New | +$799K |
|
2642
CALL
NewMarket
NEU
$7.13B
| $867K | ﹤0.01% |
2,000
-5,000
| -71% | -$2.11M |
|
|
ALLK
2643
DELISTED
Allakos
ALLK
| $865K | ﹤0.01% |
+21,352
| New | +$863K |
|
2644
CALL
Sun Communities
SUI
$15B
| $865K | ﹤0.01% |
+7,300
| New | +$812K |
|
2645
PUT
Everest Group
EG
$15.4B
| $864K | ﹤0.01% |
4,000
-11,900
| -75% | -$2.59M |
|
|
GRMN
2646
PUT
Garmin
GRMN
$46.8B
| $864K | ﹤0.01% |
+10,000
| New | +$753K |
|
2647
Minerva Neurosciences
NERV
$196M
| $860K | ﹤0.01% |
13,675
+2,276
| +20% | +$137K |
|
|
PRFT
2648
DELISTED
Perficient Inc
PRFT
| $860K | ﹤0.01% |
31,405
-59,594
| -65% | -$1.57M |
|
|
SGMO
2649
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $859K | ﹤0.01% |
90,000
| – | – |
|
|
CRHM
2650
DELISTED
CRH Medical Corporation
CRHM
| $858K | ﹤0.01% |
324,600
+400
| +0.1% | +$1.24K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.